Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Did your doctor get COVID? new study checks antibodies in primary care workers

NCT ID NCT04808986

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study tested nearly 2,800 primary care health workers (like doctors, pharmacists, and dentists) and their household members in France for COVID-19 antibodies. The goal was to find out how many had been exposed to the virus and to understand risk factors. Participants used a simple finger-prick blood test at home and mailed it in for analysis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help public health officials better understand how many primary care workers and their families were exposed to COVID-19, guiding future vaccination and safety protocols.
What could go wrong
This is an observational study, not a treatment trial. It only measures past exposure, not protection from future infection. Results may not apply to other regions or time periods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,817 people

The number who actually took part.

Started

May 2021

Finished

Oct 2021

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Health professionals in primary care : * General practitioners, paediatricians, pharmacists, pharmacy assistants, dental surgeons or dental assistants practising in metropolitan France at the time of inclusion (condition ensured by affiliation to one of the four networks); * Be affiliated to one of the following networks: Sentinelles, AFPA, IQVIA, ReCOL or work in a city pharmacy (for pharmacy assistants) or in a dental practice (dental assistants) whose owners are affiliated to these networks; * To be a volunteer to participate in the study; * To have given their agreement in principle to the collection of data (including personal data) necessary for recruitment; * Have given their consent to participate in the study; * To be affiliated to a social security scheme or to be a beneficiary of such a scheme. Members of health professionals' households : * Occupy the same dwelling as a healthcare professional included in PHASE 1 of the COVID-SeroPRIM study at least 2 days per week (including weekend attendees, every other week, etc.) at the time of inclusion in the study, without necessarily being related; * To have volunteered to participate in the study; * To have given their consent to participate in the study or, in the case of minors, consent given by the representative(s) of the parental authority; * To be able to understand the study process, to fill in the questionnaires and to take the planned samples (if the person included is old enough to understand). Exclusion criteria : * Persons subject to a legal protection measure (safeguard of justice, curatorship, guardianship); * Persons who have participated in clinical trials to test chemoprophylaxis to prevent infection with SARS-CoV-2. * Minors who do not have a parent or guardian in the health professional's household

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut Pierre Louis Epidemiologie Et Sante Publique

    Paris, 75012, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.